Literature DB >> 25285062

Synthesis and Evaluation of an O-Aminated Naphthol AS-E as a Prodrug of CREB-mediated Gene Transcription Inhibition.

Fuchun Xie1, Bingbing X Li1, Xiangshu Xiao2.   

Abstract

An O-aminated naphthol AS-E was designed as a prodrug to achieve reductive activation and improved aqueous solubility. During the synthesis of this designed compound, a novel transformation from aryl triflates and ethyl acetohydroximate to oxazoles was discovered. Although the initially designed O-amino naphthol AS-E was not made successfully, the eventually synthesized O-tert-butylamino derivative was found to be biologically inactive, suggesting that reductive N-O cleavage in this compound was not facile due to unfavorable steric and electronic effects.

Entities:  

Keywords:  CREB; O-amination; ethyl acetohydroximate; naphthol AS-E; oxazole; prodrug; reductive activation

Year:  2013        PMID: 25285062      PMCID: PMC4184210          DOI: 10.2174/1570178611310050014

Source DB:  PubMed          Journal:  Lett Org Chem        ISSN: 1570-1786            Impact factor:   0.867


  11 in total

1.  Conformationally rigid aromatic amino acids as potential building blocks for abiotic foldamers.

Authors:  Veera V E Ramesh; Arup Roy; Kuruppanthara N Vijayadas; Amol M Kendhale; Panchami Prabhakaran; Rajesh Gonnade; Vedavati G Puranik; Gangadhar J Sanjayan
Journal:  Org Biomol Chem       Date:  2010-11-17       Impact factor: 3.876

2.  Design, synthesis, and biological evaluation of conformationally constrained analogues of naphthol AS-E as inhibitors of CREB-mediated gene transcription.

Authors:  Min Jiang; Bingbing X Li; Fuchun Xie; Frances Delaney; Xiangshu Xiao
Journal:  J Med Chem       Date:  2012-04-09       Impact factor: 7.446

3.  Pd-catalyzed O-arylation of ethyl acetohydroximate: synthesis of O-arylhydroxylamines and substituted benzofurans.

Authors:  Thomas J Maimone; Stephen L Buchwald
Journal:  J Am Chem Soc       Date:  2010-07-28       Impact factor: 15.419

4.  Design, synthesis, and evaluation of duocarmycin O-amino phenol prodrugs subject to tunable reductive activation.

Authors:  James P Lajiness; William M Robertson; Irene Dunwiddie; Melinda A Broward; George A Vielhauer; Scott J Weir; Dale L Boger
Journal:  J Med Chem       Date:  2010-11-11       Impact factor: 7.446

5.  Glutathione levels and variability in breast tumors and normal tissue.

Authors:  R R Perry; J A Mazetta; M Levin; S C Barranco
Journal:  Cancer       Date:  1993-08-01       Impact factor: 6.860

6.  A unique class of duocarmycin and CC-1065 analogues subject to reductive activation.

Authors:  Wei Jin; John D Trzupek; Thomas J Rayl; Melinda A Broward; George A Vielhauer; Scott J Weir; Inkyu Hwang; Dale L Boger
Journal:  J Am Chem Soc       Date:  2007-11-17       Impact factor: 15.419

7.  Discovery of a small-molecule inhibitor of the KIX-KID interaction.

Authors:  Bingbing X Li; Xiangshu Xiao
Journal:  Chembiochem       Date:  2009-11-23       Impact factor: 3.164

8.  Structure-activity relationship studies of naphthol AS-E and its derivatives as anticancer agents by inhibiting CREB-mediated gene transcription.

Authors:  Bingbing X Li; Kinrin Yamanaka; Xiangshu Xiao
Journal:  Bioorg Med Chem       Date:  2012-10-04       Impact factor: 3.641

9.  Design and synthesis of a cell-permeable synthetic transcription factor mimic.

Authors:  Xiangshu Xiao; Peng Yu; Hyun-Suk Lim; Devanjan Sikder; Thomas Kodadek
Journal:  J Comb Chem       Date:  2007-05-27

10.  Total synthesis of the aspercyclides.

Authors:  Jirí Pospísil; Christoph Müller; Alois Fürstner
Journal:  Chemistry       Date:  2009-06-08       Impact factor: 5.236

View more
  4 in total

1.  Design, synthesis and biological evaluation of regioisomers of 666-15 as inhibitors of CREB-mediated gene transcription.

Authors:  Fuchun Xie; Bingbing X Li; Xiangshu Xiao
Journal:  Bioorg Med Chem Lett       Date:  2016-12-31       Impact factor: 2.823

Review 2.  What turns CREB on? And off? And why does it matter?

Authors:  André Steven; Michael Friedrich; Paul Jank; Nadine Heimer; Jan Budczies; Carsten Denkert; Barbara Seliger
Journal:  Cell Mol Life Sci       Date:  2020-04-28       Impact factor: 9.261

3.  A suite of bioassays to evaluate CREB inhibitors.

Authors:  Bingbing X Li; Xiangshu Xiao
Journal:  Methods Enzymol       Date:  2019-11-22       Impact factor: 1.682

4.  Systemic Inhibition of CREB is Well-tolerated in vivo.

Authors:  Bingbing X Li; Ryan Gardner; Changhui Xue; David Z Qian; Fuchun Xie; George Thomas; Steven C Kazmierczak; Beth A Habecker; Xiangshu Xiao
Journal:  Sci Rep       Date:  2016-10-03       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.